(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3... University of Liverpool had proposed that patient...t from medication.// They say that it is advisable...ptic patients. Researchers of the study feel that ...ficantly benefit the patients in having a better q...
...ccess of the World Health Day 2000 with the theme ...orld Blood Donors Day.// The date coincides with t...the ABO blood group system. The International Bl...y by the International Federation of Blood Donor O...
... analysis has been developed as a tool to diagnose...and Harvard. Researchers have also been able to de...icroRNA profile through an easy and not expensive ... small RNA molecules that control the level of pro...
...n reduce the rate of negative appendectomy by a si... imaging is also known as Computerized Axial Tomog...sectional images that may be used as a diagnostic ...iseases and health conditions. Negative appendecto...
Other Medicine News:(Date:10/2/2008)...XFORD, England, October 2 /- Circassi...ed on the fields of allergy and critical,care, tod...cal study of its,ToleroMune(R) technology in the f...results achieved in an earlier phase II study, whi... the ToleroMune approach to allergy,desensitizatio...
(Date:10/1/2008)...AMBRIDGE, Mass., Oct. 1 /- Ironwood P... $50 million in a private equity financing.,This c...se 3 development,program evaluating linaclotide fo...onstipation (IBS-C) and chronic constipation (CC),...covered drug candidates, and to,expand commercial ...
(Date:10/1/2008)...ALIFAX, Oct. 1 / ImmunoVaccine Techno...DepoVax(TM) is showing positive,pre-clinical resul...tic,cancer and several infectious disease vaccine ...nted October 4th at the Ehrlich II conference in,G... will also be reporting,on the capabilities of IVT...
(Date:10/1/2008)...nces in diagnostics and genetic testing give women... risks, DAYTON, Ohio, Oct. 1 /- Ac...p (2007), an estimated 182,460 new cases of breast...8. And while screening,programs are resulting in t...e easily and successfully treated, breast cancer c...
Breaking Medicine Technology:Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 2Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3 3ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 3Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 4Study reveals surprising details of the evolution of protein translation 4435 1Study reveals surprising details of the evolution of protein translation 4435 2AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 1AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 2AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 3AdvaMed 2008 Supporting Partner Organizations Up 30 25 Over Last Year 25347 4Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 1Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 2Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2825 4Temple Fox Chase and Geisinger create Keystone Institute for Translational Medicine 25344 1Temple Fox Chase and Geisinger create Keystone Institute for Translational Medicine 25344 2...tin Demonstrated Statistically,Significant Improve...IN, March 22, 2007 /PRNewswire-FirstCall/ -- Pharm... additional data from,the double-blind, randomized...RC trial (Satraplatin and Prednisone Against,Refra...nd Annual,European Association of Urology Congress...
...g Virus Enzyme to Treat Mouse Model,of Acute Otiti...,Prevent Both Ear Infection and Pneumonia in Peopl...PRNewswire/ -- Parents might one,day give their ch...rus enzymes to prevent them from getting a severe ...done in mice by,investigators from St. Jude Childr...
Other Medicine Technology:Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7Viral Enzyme Recruited in Fight Against Ear Infection 2Viral Enzyme Recruited in Fight Against Ear Infection 3...extremely popular to combine a Flat Screen LCD Mon...fords the surgeon optimal viewing of the monitor w... Dual Light System has the capability of including...n be purchased separately and the Monitor(s) purch...
...e of a major surgical light yet is packaged and pr...or Procedure Rooms, C-Section, E.R. as well as LDR...OR table is becoming a very popular set-up in a Ge...ith the lights. The smooth, easy-to-clean lines c...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum.
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously.
Medicine Products: